Trial intelligence / Profile preview

Recovery of adrenal insufficiency after high-dose corticosteroid-containing chemotherapy in diffuse large B cell lymphoma

TCTR20211126002Recruiting

Sponsor
Siriraj Hospital
Start
Feb 2020
Countries
1
01

Overview

Open-label, single-arm trial of corticosteroids in diffuse large B-cell lymphoma (DLBCL), sponsored by Siriraj Hospital. Primary endpoints: Rate of recovery from adrenal insufficiency and Time to recovery from adrenal insufficiency. Started Feb 2020; status: recruiting.

02

Drugs

corticosteroids
03

Conditions

diffuse large B-cell lymphoma (DLBCL)

Beyond the preview

Go deeper on TCTR20211126002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20211126002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call